Biotechnology & Nanotechnology

Plasma © SusTech

Hessen is a first-class location for biotechnology companies: A large number of research institutes, universities and private educational providers offer the state’s roughly 225 biotech businesses an ideal environment in which to develop new technologies and products. Marburg has attracted many companies in the fields of pharmaceutics, biotechnology and health. Notable examples are CSL Behring GmbH, one of the area’s largest employers, which maintains its largest production and research facility here, and the vaccines and diagnostics division of the Swiss company Novartis, which set up the world’s first facility for producing flu vaccine from cell cultures in Marburg.

Hessen has many more big players: Fresenius is headquartered in Bad Homburg, Merck in Darmstadt and Stada in Bad Vilbel. Technology centres such as the Frankfurter Innovationszentrum für Biotechnologie (FIZ) host companies in the life sciences sector and interdisciplinary networks, as well as comprehensive consulting services on the implementation of their business ideas.

About 80 working groups are active in the field of nanoscience and nanotechnology. They prepare the way for global corporations such as Evonik and Heraeus as well as new research companies. Nanotechnology is a core business for more than 150 companies in Hessen and is highly relevant to 500 more firms in related fields.

“An established core of expertise at the company’s local site, the availability of highly qualified personnel and the region’s high-capacity infrastructure are significant reasons why Sanofi-Aventis not only maintains one of the world’s largest and most modern facilities for the biotechnical production of insulin at Frankfurt-Höchst, but has also pressed on with the expansion of the related supply chain.”

Dr. Martin Siewert, Managing Director, Sanofi-Aventis Deutschland GmbH


  • Sanofi-Aventis
  • Novartis
  • Evonik
  • Heraeus
  • Stada
  • Fresenius
  • CSL Behring
  • Merck
  • Brain